0001209191-15-056014.txt : 20150624 0001209191-15-056014.hdr.sgml : 20150624 20150624182011 ACCESSION NUMBER: 0001209191-15-056014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150623 FILED AS OF DATE: 20150624 DATE AS OF CHANGE: 20150624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MITCHELL W THOMAS CENTRAL INDEX KEY: 0001214352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 15950190 MAIL ADDRESS: STREET 1: 48030 PASO TIEMPO LN CITY: LA QUINTA STATE: CA ZIP: 92253 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-23 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001214352 MITCHELL W THOMAS 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 Common Stock 2015-06-23 4 M 0 15000 6.66 A 16000 D Common Stock 2015-06-23 4 S 0 15000 49.35 D 1000 D Non-qualified Stock Option 6.66 2015-06-23 4 M 0 15000 6.66 D 2022-05-23 Common Stock 15000 0 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. The option was granted May 23, 2012 and vested in 12 equal monthly installments beginning June 23, 2012. /s/Darin Lippoldt, attorney-in-fact 2015-06-24